Post-approval studies (Phase 4)Study completedNCT03629379
What this trial is testing
Response to Ustekinumab for Anti-tnf Induced Psoriasiform Skin Lesions
Who this might be right for
Inflammatory Bowel DiseasesPsoriasis
Universitaire Ziekenhuizen KU Leuven 20